A comparison of genome-wide DNA methylation patterns between rectal cancer and normal rectal epithelial cells showed that the MGMT (O6-alkylguanine DNA alkyltransferase) gene promoter has more methylated sites in the cancer cells than in the epithelial cells, resulting in decreased MGMT expression and impaired DNA damage repair in the cancer cells [1]. This evidence concerns the gene MGMT and rectal cancer.